endothelin converting enzyme inhibitors (Abbott)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameendothelin converting enzyme inhibitors (Abbott)
Drug Alias NameECE inhibitors (Abbott)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin-converting enzymes inhibitors
TargetsEndothelin-converting enzymes
Therapy Area/IndicationsHeart FailureAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsHeart FailureAsthma

Other Information

ATC CodeN/A
Related LinksN/A